HAEMATO AG (HAEK) Price & Analysis

1 Followers

HAEK Stock Chart & Stats

€10.30

-€0.40(-1.83%)

At close: Feb 29 4:00 PM EST

€10.30

-€0.40(-1.83%)

Day’s Range― - ―

52-Week Range€8.20 - €13.60

Previous CloseN/A

Volume1.79K

Average Volume (3M)711.00

Market Cap

€68.26M

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta-0.62

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding5,229,307

10 Day Avg. Volume943

30 Day Avg. Volume711

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

HAEMATO AG News

HAEMATO AG (HAEK) Announces Q3 Dividend: Read On for Important Dates

HAEMATO AG (XETRA: HAEK) has declared, under its dividend policy, a yearly cash dividend in the amount of...

3y ago

HAEK FAQ

What was HAEMATO AG’s price range in the past 12 months?

HAEMATO AG lowest stock price was €8.20 and its highest was €13.60 in the past 12 months.

What is HAEMATO AG’s market cap?

HAEMATO AG’s market cap is €68.26M.

When is HAEMATO AG’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were HAEMATO AG’s earnings last quarter?

Currently, no data Available

Is HAEMATO AG overvalued?

According to Wall Street analysts HAEMATO AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does HAEMATO AG pay dividends?

HAEMATO AG does not currently pay dividends.

What is HAEMATO AG’s EPS estimate?

HAEMATO AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does HAEMATO AG have?

HAEMATO AG has 5,229,307 shares outstanding.

What happened to HAEMATO AG’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of HAEMATO AG?

Currently, no hedge funds are holding shares in DE:HAEK

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

HAEMATO AG Stock Smart Score

Neutral

Top Smart Score Stocks >

Company Description

HAEMATO AG

HAEMATO AG is a Germany based pharmaceutical company. It provides pharmaceuticals for the care of chronically ill people. The firm is engaged in the sale of generic and EU (European countries) import drugs. It is focused on patented and non-patented medicinal products. The company product portfolio includes human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), neurology, oncology, rheumatology, and urology. Geographically, it operates only in Germany.